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AbstrAct
Objectives This study aimed to evaluate whether use of a 
discharge criteria tool for nursing assessment of patients 
in Post Anaesthesia Care Unit (PACU) would enhance 
nurses’ recognition and response to patients at-risk of 
deterioration and improve patient outcomes.
Methods A prospective non-randomised pre–post 
intervention study was conducted in three hospitals in 
Australia. Participants were adults undergoing elective 
surgery before (n=723) and after (n=694) implementation 
of the Post-Anaesthetic Care Tool (PACT).
results Nursing response to patients at-risk of 
deterioration was higher using PACT, with more medical 
consultations initiated by PACU nurses (19% vs 30%, 
P<0.001) and more patients with Medical Emergency 
Team activation criteria modified by an anaesthetist while 
in PACU (6.5% vs 13.8%, P<0.001). There were higher 
rates of analgesia administration (37.3% vs 54.2%, 
P=0.001), nursing assessment of pain and documentation 
of ongoing analgesia prior to discharge (55% vs 85%, 
P<0.001). More adverse events were recorded in PACU 
after introduction of the PACT (8.3% vs 16.7%, P<0.001). 
The rate of adverse events after discharge from PACU 
remained constant (16.5%), but the rate of cardiac events 
(5.1% vs 2.6%, P=0.021) and clinical deterioration (8.7% 
vs 4.3%, P=0.001) following PACU discharge significantly 
decreased, using the PACT. Despite the increased number 
of patients with adverse events in phase 2, healthcare 
costs did not increase significantly. Length of stay in PACU 
and length of hospital admission for those patients who 
had an adverse event in PACU were significantly reduced 
after implementation of the PACT.
conclusion This study found that using a structured 
discharge criteria tool, the PACT, enhanced nurses’ 
recognition and response to patients who experienced 
clinical deterioration, reduced length of stay for patients 
who experienced an adverse event in PACU and was cost-
effective.
bAckgrOund 
Surgery is an integral part of healthcare 
throughout the world, with an estimated 
234 million operations performed annually.1 
Studies in industrialised countries have 
shown a death rate after surgery of 0.4% to 
4.0% and a rate of major complications of 3% 
to 17%.2–6 Approximately 40% of in-hospital 
complications are associated with surgery 
and 15% of surgical patients will experi-
ence at least one complication,7 such as 
bleeding, infection, cardiac and/or respira-
tory problems (congestive cardiac failure and 
pulmonary oedema); these being the most 
commonly occurring events.8 Hospital costs 
for surgical patients experiencing a complica-
tion are substantially higher than for patients 
without a complication.9 10 
The intensive observation of patients in 
PACU by nurses can result in the early detec-
tion of complications and adverse events.11 
These adverse events include clinical deteri-
oration, unresolved pain, unplanned admis-
sion to intensive care, prolonged hospital 
stay, disability or death. Postoperative dete-
rioration occurs frequently, with a reported 
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Research
strengths and limitations of this study
 ► This study examined the real-time impact of nursing 
care, for the recognition and response to patient
deterioration in the Post Anaesthesia Care Unit.
 ► The prospective design identified processes relating
to nursing management not captured in the medical
record.
 ► The sourcing of some data obtained from patients’
medical record and organisational datasets was a
limitation of the study. For most variables, including
key outcome variables, the frequency of missing
data was less than 1%.
 ► There may be factors external to the implementation 
of the Post-Anaesthetic Care Tool  that increased
or decreased surgical risk; however, this quasi-
experimental study design was practical and
effective health services research.
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rate of 20% in PACU and 17% on the wards12 and 20% 
of patients who experienced clinical deterioration in 
PACU required medical review.13 The early recognition 
of clinical deterioration and timely response can reduce 
the incidence or severity of postoperative complications, 
mortality and length of hospital stay.14
AiMs
The aims of this study were to evaluate whether use of the 
Post-Anaesthetic Care Tool (PACT) would (1) enhance 
the recognition and response to patients at risk of clinical 
deterioration, (2) result in improved patient outcomes 
and (3) reduce healthcare costs.
MethOds
design
This study used a non-randomised prospective before and 
after intervention design. The study protocol has been 
published15; therefore, a brief overview is provided here. 
The setting for the study was the Post Anaesthesia Care 
Units (PACUs) at three hospitals within one Australian 
metropolitan healthcare organisation using primarily 
non-participant observation.
development of the tool
The intervention was the PACT, developed locally to 
address concerns raised by clinicians and managers about 
the lack of standardised documentation within the periop-
erative services of the healthcare organisation, which was 
impacting on patient outcomes immediately following 
surgery. For example, one hospital was using a modi-
fied Aldrete scoring system16 to assess patient readiness 
for discharge from PACU while another used a simple 
checkbox. A working party was established to determine 
the best way to address these issues and improve outcomes 
for patients. An interdisciplinary subcommittee including 
nursing and medical health professionals, quality assur-
ance and planning representatives and the researchers 
who were experienced in exploring PACU evaluation 
tools undertook extensive review of the current processes 
at each hospital. The researchers conducted two proj-
ects, a systematic review17 and an expert consensus 
study,18 to synthesise and evaluate the current evidence 
and generate key elements to form a new PACT for safe 
patient discharge from PACU. The findings from these 
two studies were considered and incorporated into the 
PACT when the new assessment documentation for 
perioperative care at this health organisation was devel-
oped between March 2011 and November 2012.
Changes to the PACT were also required to conform 
to organisational policy and procedures, especially with 
regard to guidelines relating to the recognition and 
response to patient clinical deterioration. These guide-
lines included the use of colour-coded charts that incor-
porated a track and trigger system, where different 
colours in the charts reflect levels of physiological 
abnormality or specific triggers in single or multiple 
parameter systems.19 Medical emergency team (MET) 
activation occurs when patients fulfil predefined criteria 
(specific abnormalities in vital signs or staff concern).20 
The revised documentation (PACT) conformed to the 
National Consensus Statement on the essential elements 
for recognising and responding to clinical deterioration21 
and used a track and trigger system for assessment of a 
patient’s conscious state, vital signs (oxygen levels, respi-
ration rate, blood pressure and temperature), symptoms 
(pain, nausea and vomiting), level of activity and care 
plan. Patient readiness for discharge from PACU was 
recorded by a checklist of criteria: that the last two sets 
of observations were not within the MET or modified 
MET criteria; there was no active vomiting; pain manage-
ment had been ordered; and all surgical concerns had 
been met.15 The PACT contained information regarding 
oxygen therapy, analgesia administered in PACU and 
related charts specific to the patient and surgical proce-
dure (see online supplementary figure S1).
implementation of PAct
Implementation of the PACT was supported by periop-
erative nursing educators, posters summarising how to 
complete the PACT and feedback sessions between the 
nurses using the tool and the perioperative team (educa-
tors, nurse unit managers and the quality unit of the 
organisation). The PACT was included in the revised 
‘Post-Anaesthetic Care Record’ and was implemented at 
all three hospitals on the same day in March 2014. Postim-
plementation data collection commenced after a 3-month 
period from the time of implementation, as this was 
considered sufficient time for the tool to be embedded in 
nursing practice in PACU.
Participants
The study population comprised surgical patients 
admitted to the PACU during the study period. All 
adult patients (18 years or over) undergoing elective 
surgery on days of data collection before (phase 1; July 
to October 2012) and after (phase 2; July to September 
2014) the implementation of PACT were eligible to be 
included. Patients were excluded from the study if they 
had undergone emergency surgery, had a minor proce-
dure requiring only sedation rather than anaesthesia or 
had a postoperative planned admission to intensive care. 
The sample size was based on an adverse event incidence 
of 12% and able to detect a 7% difference before and 
after the PACT, or an OR of at least 2.6, using a two-sided 
Cochran-Mantel-Haenszel (CMH) test conducted at the 
5% significance level with 80% power.
Data, collected by research nurses, were patient demo-
graphics, physiological parameters, clinical nursing care, 
handover to ward nurse including duration, length of 
stay in PACU, length of hospital admission and patient 
outcomes, including any adverse events or complications. 
Complications and serious adverse events included clin-
ical deterioration, prolonged stay in PACU, unplanned 
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return to theatre, unplanned admission to intensive care 
unit (ICU) or readmission to hospital and were defined 
as any deviation from the normal postoperative course.22 
Clinical deterioration was determined through assessment 
of respiration (difficulty in breathing, respiration rate less 
than 8 or greater than 30 per min; oxygen saturation less 
than 90% despite oxygen therapy), circulation (heart rate 
less than 50 or more than 130 beats/min, systolic blood 
pressure less than 90 mm Hg) or change in conscious 
state.15 Severity of each adverse event was graded using 
the Common Terminology Criteria for Adverse Events 
V.4.03,23 and grouped into mild (an event which caused
no or minimal effect to the patient and resolved sponta-
neously), moderate (an event which resolved after inter-
vention, with no lasting effect for the patient) and severe
(an event which required intervention and caused harm
to the patient, including death).
The primary outcomes were the rate of complications, 
adverse events and mortality, the length of stay in PACU 
and length of hospital admission. Patient outcomes were 
determined from the medical record following hospital 
discharge. An economic evaluation was also undertaken, 
from organisational data that were routinely submitted to 
the regional health department for benchmarking.
Statistical analyses were undertaken to describe the 
two groups and identify differences between phases 1 
and 2, before and after implementation of the PACT. In 
order to account for hospitals’ heterogeneity the CMH 
test was used to compare the proportion of adverse 
events and mortality between the two groups, adjusting 
for hospital strata as an effect modifier factor. ORs for 
risk of an adverse event were adjusted for age, gender, 
American Society of Anesthesiologist (ASA) score, type of 
surgery and admission type (inpatient or day/short stay) 
using logistic regression. Length of time in PACU, and 
length of hospital admission were considered as time-to-
event data. Survival rates were calculated and illustrated 
by the Kaplan-Meier method and further analysed by the 
log-rank test (stratified by hospitals).
economic evaluation
In Australia, healthcare costs for each patient admitted 
to hospital are calculated on a cost–weight analysis using 
the Australian Refined—Diagnostic-Related Groups 
(AR-DRGs). The AR-DRG is ‘an Australian admitted 
patient classification system which provides a clinically 
meaningful way of relating the number and type of 
patients treated in a hospital to the resources required 
by the hospital’.24 In this study, the AR-DRG was used to 
calculate the costs for all initial admissions and unplanned 
readmissions, using the national efficient price deter-
mination.25 A weighted average cost of an unplanned 
admission to an ICU of $A190/hour was taken from the 
National Pricing Model Technical specifications 2014–
2015.26 The cost of emergency department visits was 
assumed to be that of a non-admitted return visit, Triage 
4, 5 ($A201 per encounter) as reported by the Indepen-
dent Hospital Pricing Authority.26 To be included in the 
cost analysis, each patient needed to have all episodes of 
care recorded, including the code for diagnosis-related 
group (DRG) and length of stay for the initial admis-
sion. A review of the data provided by the health network 
administration found that details of the procedure, diag-
nosis and consequent DRG coding were not available for 
all enrolled patients. Those patients with missing data 
were excluded from the cost analysis.
results
In total, 1417 patients were included in this study, 723 in 
phase 1 and 694 in phase 2. Almost half the patients were 
day surgery cases (48%, n=679) with the remainder being 
overnight (26%, n=369), or multiday admissions (26%, 
n=369). Surgical specialties in this study were: general 
(open and laparoscopic abdominal surgery), obstetric 
and gynaecological, orthopaedic, urology, plastics, ear, 
nose and throat, vascular and thoracic. There were no 
differences in the average age, gender distribution or 
patients’ physical status prior to surgery for both groups 
(table 1). However, there were more obstetric and gynae-
cological and fewer general surgery procedures in phase 
2 (table 1).
nursing management of patient symptoms
Following the implementation of the PACT, it was found 
that nursing responses to patients with clinical deteriora-
tion were higher. There were more requests for medical 
review by PACU nurses (19% vs 30%, P<0.001) and 
more patients with MET activation criteria modified by 
an anaesthetist while in PACU (6.5% vs 13.8%, P<0.001) 
using the PACT. There were higher rates of analgesia 
administration (37.3% vs 54.2%, P=0.001) for patients in 
pain, and there was also a significant increase in nursing 
assessment and documentation that ongoing pain relief 
had been ordered prior to discharge from PACU (55.3% 
vs 84.8%, P<0.001).
For the 16.1% (n=228) of patients experiencing nausea 
and vomiting in PACU, there were more assessments 
and documentation relating to this after introduction of 
the PACT (60.0% vs 92.4%, P<0.001). In addition, this 
led to an increase in antiemetics being administered to 
a significantly higher proportion of patients with nausea 
and vomiting in phase 2, compared with phase 1 (49.2% 
vs 84.8%, P=0.002).
Patient outcomes
Patient outcomes included rates of adverse events and 
mortality, the length of stay in PACU, length of hospital 
admission and discharge destination.
Adverse events
In total, 25.2% (357/1417) of patients experienced 379 
adverse events following surgery; one-third occurred in 
PACU (33.9%, 121/357). The most common adverse 
events in PACU in both phases were clinical deteriora-
tion, other cardiovascular and respiratory events which 
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Table 1 Patient characteristics before (phase 1) and after (phase 2) implementation of the Post Anaesthetic Care Tool
Patient characteristic
Phase 1, 
N=723, 
n (%)
Phase 2, 
N=694, 
n (%) P value
Age years: mean (SD) 52.14 (18.6) 50.87 (17.4) 0.186
Gender 
 Male 301 (41.6) 269 (38.8) 0.257
 Female 422 (58.4) 425 (61.2)
ASA score
 1 211 (32.5) 190 (32.9) 0.134
 2 305 (47.0) 278 (48.1)
 3 115 (17.7) 102 (17.6) 
 4 18 (2.8) 6 (1.0) 
 Not recorded 74 (10.2) 118 (16.7) 
Charleson Comorbidity score
 Low (<2) 587 (81.1) 582 (83.9) 0.407
 Moderate (2–4) 114 (15.7) 95 (13.7) 
 High (>4) 22 (3.0) 17 (2.4) 
Admitting hospital 
 Hospital A 244 (33.7) 244 (35.2) 0.648
 Hospital B 294 (40.7) 287 (41.4) 
 Hospital C 185 (25.6) 163 (23.5) 
Day of surgery 
 Monday 165 (22.8) 104 (15.0) 0.001*
 Tuesday 167 (23.1) 199 (28.7) 
 Wednesday 127 (17.6) 118 (17.0) 
 Thursday 144 (19.9) 129 (18.6) 
 Friday 120 (16.6) 144 (20.7) 
Surgical category 
 General 278 (38.5) 243 (35.0) 0.007*
 Obstetric and gynaecological 139 (19.2) 177 (25.5) 
 Orthopaedic 143 (19.8) 101 (14.6) 
 Urology 67 (9.3) 76 (11.0) 
 Plastics 60 (8.3) 50 (7.2) 
 Ear, nose and throat 24 (3.3) 21 (3.0) 
 Vascular 12 (1.7) 22 (3.2) 
 Thoracic 0 (0) 4 (0.6) 
Admission type 
 Inpatient 407 (56.3) 333 (48.3) 0.003*
 Day/short stay 316 (43.7) 357 (51.7) 
*P<0.05.
ASA, American Society of Anesthesiologists.
required intervention and unresolved severe pain (pain 
score of at least 8 out of 10 after analgesia; figure 1).
The number of adverse events recognised and 
recorded significantly increased from 21.2% (153/723) 
in phase 1 to 29.4% (204/694) in phase 2 (P<0.001). 
As shown in table 2, there was greater recognition of 
adverse events in PACU following the implementation 
of the PACT, as more adverse events were recorded in 
PACU during phase 2 (OR 2.08, 95% CI 1.49 to 2.91, 
P<0.001). In particular, there was a significant increase 
in the detection of cardiovascular events (OR 2.51, 
95% CI 1.55 to 4.06, P<0.001) and respiratory events 
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Figure 1 Frequency of patients experiencing adverse events in Post Anaesthesia Care Unit (PACU) (blue), after discharge from 
PACU (green) and starting in PACU and continuing after discharge from PACU (red) for both phases combined. ICU, intensive 
care unit; MET, medical emergency team. 
(OR 4.29, 95% CI 1.19 to 15.40, P=0.032) and an 
increase in episodes of unresolved pain recorded in 
PACU (OR 2.57, 95% CI 1.42 to 4.66, P=0.002). There 
was no significant difference in the rate of clinical dete-
rioration (OR 0.86, 95% CI 0.50 to 1.47, P=0.579).
While the rates of all events occurring in PACU 
increased in phase 2, the rates of these same events 
following PACU discharge decreased or remained the 
same after the implementation of the PACT (figure 2). 
There was a significant decrease in the rates of clinical 
deterioration (OR 0.47, 95% CI 0.30 to 0.74, P=0.001) 
and cardiovascular events (OR 0.49, 95% CI 0.28 to 0.88, 
P=0.021) on the ward in phase 2 (table 2).
The severity of the 379 adverse events in both phases 
was graded as mild for 31.3% (119/379), moderate for 
64.4% (244/379) and severe for 4.2% (16/379). There 
was a significant increase in the proportion of patients 
with moderately severe adverse events in phase 2 
(ORCMH=1.67, 95% CI 1.26 to 2.21, P<0.001), but there 
was no difference in the rate of mild or severe adverse 
events (table 2). This increase in moderate adverse events 
was greater in PACU (ORCMH=1.75, 95% CI 1.19 to 2.58, 
P=0.001) than for events which occurred after discharge 
from PACU (ORCMH=1.30, 95% CI 0.93 to 1.82, P=0.125).
As reported in table 1, there were fewer general and 
orthopaedic surgical procedures in phase 2 compared 
with phase 1 (reduced by 3.5% and 5.2%, respectively) 
while there was more obstetric and gynaecological surgery 
(increased by 6.3%). These differences were significant. 
Therefore, in comparing the adverse event rates in each 
phase, logistic regression was conducted to adjust for type 
of surgery, ASA status, admission type, gender and age 
(online supplementary table S1). Adjustment was made 
only for all adverse events in PACU, as this was the adverse 
event rate that was significant overall. No adjustment for 
subanalysis was conducted due to small sample size. As 
illustrated in online supplementary table S1, adjusted OR 
showed negligible change from the unadjusted OR.
The median length of stay for all patients in PACU was 
49.0 min (95% CI 47.7 to 50.3), with a range from 6 min 
to 9.2 hours. Approximately 1 in 20 (4.4%, n=63/1417) 
patients remained in PACU longer than 2 hours. The 
most common reasons for discharge delay were patient 
transfer delay due to unavailability of ward nurses for 
PACU patient handover (6.6%) and complex recovery 
(5.9%). Compared with phase 1, more patients experi-
enced a delay in discharge from PACU in phase 2 (15.5% 
vs 25.4%, P<0.001). This was primarily due to complex 
patient recovery (3.5% vs 8.5%, P<0.001), with more 
patients fulfilling MET activation criteria while in PACU 
during phase 2 (6.5% vs 13.8%, P<0.001).
Using Kaplan-Meier survival analysis, where discharge 
from PACU was the event, there was a small but signif-
icant increase in median length of stay in PACU from 
45 min (95% CI 43.3 to 46.7) in phase 1 to 53 min (95% CI 
51.3 to 54.7, P<0.001) in phase 2 (figure 3A). In contrast, 
for patients who experienced an adverse event in PACU, 
the median length of stay in PACU decreased significantly 
from 100 min (95% CI 83.8 to 116.2) in phase 1 to 83 min 
(95% CI 68.9 to 97.1, P=0.017) in phase 2 (figure 3B).
These differences in PACU length of stay are shown 
in table 3, where the results of a Cox regression are 
presented. Patients in phase 1 had significantly shorter 
median length of stay compared with those in phase 2, 
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Table 2 Mantel-Haenszel common Odds Ratio estimates comparing frequency of adverse events before (phase 1) and after 
(phase 2) implementation of the PACT
Phase 1, 
N=723, 
n (%)
Phase 2, 
N=694, 
n (%) OR 95% CI P value†*
Severity of adverse events
 Severe 10 (1.4) 6 (0.9) 0.63 0.23 to 1.74 0.368
 Moderate 99 (13.7) 145 (20.9) 1.67 1.26 to 2.21 <0.001
 Mild 55 (7.6) 64 (9.2) 1.23 0.84 to 1.79 0.330
Adverse events in PACU
 All events 60 (8.3) 116 (16.7) 2.22 1.58 to 3.07 <0.001*
 Moderately severe events 45 (6.2) 77 (11.1) 1.88 1.28 to 2.77 0.005*
 Clinical deterioration 31 (4.3) 26 (3.7) 0.86 0.50 to 1.47 0.579
 Cardiovascular 25 (3.5) 58 (8.4) 2.51 1.55 to 4.06 <0.001*
 Respiratory 3 (0.4) 12 (1.7) 4.29 1.19 to 15.40 0.032*
 Unresolved pain 16 (3.2) 38 (5.5) 2.57 1.42 to 4.66 0.002*
Adverse event after PACU
 All events 119 (16.5) 117 (16.9) 1.03 0.78 to 1.36 0.680
 Moderately severe events 69 (9.5) 84 (12.1) 1.30 0.93 to 1.82 0.125
 Clinical deterioration 63 (8.7) 30 (4.3) 0.47 0.30 to 0.74 0.001*
 Cardiovascular 37 (5.1) 18 (2.6) 0.49 0.28 to 0.88 0.021*
 Respiratory 8 (1.1) 13 (1.9) 1.68 0.69 to 4.07 0.348
 Unresolved pain 24 (3.3) 28 (4.0) 1.23 0.71 to 2.15 0.554
 Day procedure patients 33 (8.1) 36 (10.8) 1.31 0.80 to 2.13 0.285
 In patients 86 (27.2) 81 (22.6) 0.82 0.57 to 1.16 0.264
 Total adverse events 153 (21.2) 204 (29.4) 1.55 1.21 to 1.97 <0.001*
*P<0.05.
†Mantel-Haenszel test for conditional independence.
PACT, Post-Anaesthetic Care Tool; PACU, Post Anaesthesia Care Unit.
Figure 2 Frequency of patients experiencing adverse events before (P1) and after (P2) the implementation of Post-Anaesthetic 
Care Tool (PACT); events in Post Anaesthesia Care Unit (PACU) (blue), events after PACU discharge (green) and events starting 
in PACU and continuing after discharge (red).
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Figure 3 (A) Kaplan-Meier survival curves for length of 
stay in Post Anaesthesia Care Unit (PACU) for all patients 
before (phase 1, blue line) and after (phase 2, green line) 
implementation of the Post-Anaesthetic Care Tool (PACT). 
(B) Kaplan-Meier survival analysis of length of stay in PACU
for patients who experienced an adverse event in PACU,
before (phase 1, blue line) and after (phase 2, green line)
implementation of the PACT.
with a HR of 1.25 translating to the rate of discharge 
before PACT being 25% higher than after implemen-
tation of the PACT. Having an adverse event in PACU 
was associated with longer median PACU length of stay 
of 91.0 min (95% CI 84.2 to 97.8), regardless of phase. 
Following the implementation of the PACT, the median 
length of stay decreased significantly for patients who 
experienced an adverse event in PACU. The HR of 0.68 
translates to the rate of discharge after the implementa-
tion of the PACT being 47% improved compared with 
before PACT (table 3).
There was no difference in discharge destination 
from PACU for patients in phase 1 or 2. Patients were 
discharged from PACU to the day procedure unit (46%, 
n=650/1415), the short stay unit (11%, n=158/1415) or 
a ward (42%, n=600/1415). A small number of patients 
(0.5%, n=7) had an unplanned transfer from PACU to the 
intensive care unit. Four patients died during the hospital 
admission in phase 1 while no patient died during the 
hospital admission in phase 2 (P=0.022).
health service usage and healthcare costs
There was a small but significant increase in the median 
length of hospital admission from 0.5 days (IQR=1.7) in 
phase 1 to 1.0 days (IQR=1.7) in phase 2 (P=0.029). This 
was reflected in an increase in the proportion of patients 
remaining in hospital overnight from phase 1 to phase 2 
(22.1% vs 30.1%, P=0.002). After the implementation of 
the PACT, small, non-significant changes in health service 
use were noted with fewer unplanned hospital readmis-
sions in the month following discharge (3.7% vs 3.0%, 
P=0.732), and more emergency department visits (1.8% 
vs 2.5%, P=0.320).
Aggregated costs were averaged across patients with 
complete data for phase 1 (n=707) and phase 2 (n=669) 
patients, respectively (table 4). The results can therefore 
be interpreted as the expected average impact on costs 
per patient of receiving care with the PACT compared 
with those receiving care before implementation of 
PACT. The average patient acuity, determined using inde-
pendent hospital pricing authority (IPHA) cost weights 
for 2014–201525 was found to be 1.51 in phase 1 and 1.66 
in phase 2. The difference was not statistically significant, 
suggesting that any differences in costs and length of stay 
between phases 1 and 2 were not attributable to differ-
ences in the average severity of the condition of patients 
at the time of discharge.
The average cost difference for the initial surgical 
admission increased from $A5645 (n=707) in phase 1 
to $A6433 (n=669) in phase 2, an increase of $A788 per 
patient (P=0.123). Cost–weight analysis using AR-DRGs 
for initial admissions, unplanned readmissions, intensive 
care admissions and visits to the emergency department 
were included (table 4). While the average cost for the 
original admissions increased, there was a decrease in the 
number of unplanned readmissions with a consequent 
decrease in the average cost per patient. The number of 
unplanned emergency department visits after discharge 
increased, but the average cost increase per patient was 
negligible. The researchers noted one outlier with regard 
to healthcare costs, in that one patient in phase 1 was 
readmitted for 76 days, including 295 hours in inten-
sive care, with a total cost of $A239 766. This was more 
than twice the cost of the next most costly readmission 
for either phase 1 or 2 of the study. The cumulative total 
costs per patient were therefore examined using median 
values. Overall, there was a cumulative total cost increase 
of $A453 per patient following the intervention, which 
was not statistically significant (P=0.425).
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Table 3 Median length of stay in PACU before (phase 1) and after (phase 2) implementation of the PACT, for all patients and 
for those who experienced an adverse event in PACU
Median length of stay 
(min) 95% CI of median P value
Hazard
Ratio 95% CI of HR
All patients (n=1415) 49.0 47.7 to 50.3
 Phase 1* 45.0 43.3 to 46.7 P<0.001 1.25 1.13 to 1.39
 Phase 2 53.0 51.3 to 54.7
Patients with AE in PACU (n=174) 91.0 84.2 to 97.8
 Phase 1* 100.0 83.8 to 116.2 0.017 0.68 0.49 to 0.93
 Phase 2 83.0 68.9 to 97.1
Hazard Ratio given by Cox regression.
*Reference group.
AE, adverse event; PACT, Post-Anaesthetic Care Tool; PACU, Post Anaesthesia Care nit.
Table 4 Economic evaluation comparing before (phase 1) with after (phase 2) implementation of the PACT.
Phase 1, 
N=707
Phase 2, 
N=669
Observed 
difference of 
median P value†*Mean (SD) Median (95% CI) Mean (SD) Median (95% CI)
Initial admission
Length of stay (days) 1.9 (3.7) 0.5 (0.4 to 1.0) 1.9 (3.3) 1.1 (1.0 to 1.1) 0.6 <0.001* 
State average length of 
stay
2.6 (2.8) 1.6 (1.6 to 1.7) 2.3 (2.4) 1.6 (1.5 to 1.6) 0.0 0.054
Cost difference per 
patient‡ ($A)
−$A1900 (7700) −$A2400 (2100 to 2600) −$A1400 (7600) −$A1900 (1800 to 2000) $A500 0.123
Unplanned ICU 
admissions
 n (%) 5 (0.7) 2 (0.3) 
 ICU cost ($A) per patient $A19 $A6 $A4 $A4 −$A2.0 0.130 
Unplanned readmissions
 n (%) 26 (3.7) 20 (3.0) 
 Cost per patient ($A) $A809 (2648) $A199 (75 to 323) $A607 (1173) $A153 (89 to 414) −$A46 0.732
Emergency visits
 n (%) 13 (1.8) 17 (2.5) 
 Cost per patient ($A) $A4 $A4 $A5 $A5 $A1 0.320
Total cost impact per 
patient
−$A2191 −$A1738 +$A453* 0.425
*P<0.05.
†Independent samples, Mann-Whitney U test comparing median values for phases 1 and 2.
‡Difference in costs comparing actual costs with average national cost for that diagnostic-related group. A weighted average cost of an 
unplanned admission to an intensive care unit of $A190/hour and the cost of emergency department visits, was assumed to be that of a non-
admitted return visit, Triage 4, 5 ($A201 per encounter).23
PACT, Post-Anaesthetic Care Tool.
discussiOn
This study aimed to evaluate whether use of the PACT 
would (1) enhance the recognition and response to 
patients at risk of deterioration, (2) result in improved 
patient outcomes and (3) reduce healthcare costs. It is 
clear that the number of patients recognised to have an 
adverse event significantly increased after the introduc-
tion of the PACT (P<0.001), including cardiovascular and 
respiratory events and unresolved pain. Implementation 
of the PACT provided nurses with clear and comprehen-
sive criteria to assess patient readiness for discharge from 
PACU. Assessment tools which use a scoring system, such 
as the Aldrete, modified Aldrete and post-anaesthetic 
discharge scoring system (PADSS),27 28 are commonly 
used internationally. In contrast, the PACT is consis-
tent with the ‘track and trigger systems’ specified in the 
national standards of the Australian Commission on 
Safety and Quality in Health Care (ACSQHC).29 Track 
and trigger systems enable nurses to recognise and 
respond to patient deterioration by specifying thresholds 
in the observation chart using graphical colour shading 
when the patient's vital signs fall outside the ‘normal’ 
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parameters.19 30 31 According to ACSQHC, different track 
and trigger systems are used internationally, with varying 
parameters to identify level of abnormality. Importantly, 
track and trigger charts specify required responses when 
patient deterioration is recognised or when an observa-
tion threshold is crossed.21
The PACT included these thresholds in the observation 
section and specified that for safe patient discharge, the 
last two recordings of observations must not be outside 
the threshold. However, the tool allowed for modifica-
tion of these escalation factors (MET activation criteria) 
if required for an individual patient by the anaesthetist.
Following the implementation of the PACT, there was an 
increase in nurses identifying patients with adverse events 
and seeking medical review. The comprehensiveness of 
the tool enabled nurses to identify patients whose obser-
vations fell outside the normal parameters and appro-
priately respond by consulting the anaesthetist prior to 
patient discharge from the PACU, if required. Postopera-
tive deterioration has been shown to be a common event 
in PACU.12 It is therefore not surprising that using the 
PACT led to the identification of and response to more 
adverse events in the PACU and lower rates of clinical 
deterioration, cardiovascular and/or respiratory events 
and unresolved pain in the ward setting. These findings 
are also consistent with a longitudinal study of 855 870 
admissions by O’Connell and colleagues who found that 
immediately following the implementation of an observa-
tion and response chart with altered calling criteria, there 
was a sudden increase in the MET call rate of 82% which 
then gradually fell over the following 6 months, but still 
remained higher than prior to the introduction of the 
new chart.32
There are a number of studies investigating adverse 
events in the acute care setting following surgery. 
However, to our knowledge, this is the first prospective 
study to explore the influence on nursing assessment 
and management of patients in the PACU following the 
introduction of a standardised, evidence-based PACU 
discharge tool designed to promote identification of, and 
response to postoperative complications. The rates of 
adverse events reported in the current Australian study 
are similar to those reported internationally. In a survey 
of over 2000 patients admitted to one Canadian PACU, 
rates of 3.5% for excessive pain, 6.0% for nausea and 
vomiting, 1% for a critical respiratory event and 3.5% 
for cardiac related events were reported.33 Large record 
reviews of Medicare hospital admissions in the United 
States have identified postoperative complication rates 
of 13%–20%34 35 and unscheduled readmission rates of 
12.8%. An Australian study of 1291 patients found 20% of 
patients required medical review for unexpected compli-
cations.13 Although lower postoperative complication 
rates have been cited,10 other studies often limit their 
analysis to serious adverse events or to specific surgical 
procedures. In the current study, rates of many adverse 
events increased significantly after the introduction of 
the PACT. This is a positive outcome, indicating that 
the standardised discharge tool enabled nursing staff to 
better recognise and respond to deterioration before the 
patient condition became critical.
The second aim of the study was to evaluate whether use 
of the PACT would result in improved patient outcomes. 
Following the implementation of the PACT, length of 
stay in PACU and length of hospital admission decreased 
significantly for those patients who had an adverse event in 
PACU. This suggests that early detection and response to 
patients in PACU resulted in improved patient outcomes, 
specifically reduced time in PACU and hospital. Further, 
there were fewer unplanned ICU admissions and 
unplanned hospital readmissions in phase 2. There was 
a non-significant increase in emergency department visits 
within 48 hours of discharge from 13 (1.8%) in phase 1 to 
17 (2.5%) in phase 2. These severe adverse events were 
quite rare, so no statistically significant difference could 
be detected. Mild adverse events were common, but by 
definition these events do not require any intervention 
and the patient recovers from these spontaneously.
The third aim of the study was to determine through 
an economic analysis whether there was a reduction in 
healthcare costs following the intervention. The findings 
of the economic analysis confirm that the implementa-
tion of the PACT was cost-effective; the improved patient 
outcomes were not associated with any significant change 
in costs to the health service and only minor non-sig-
nificant differences between the costs for the initial 
admissions, ICU stays, emergency visits and unplanned 
readmissions were identified. There was a non-significant 
increase of the average costs per patient of $A453.
study limitations
Emergency patients, with unscheduled surgery were not 
included in this prospective study due to ethical and logis-
tical considerations, primarily relating to consent and 
incomplete documentation for emergency admissions.
We acknowledge that missing data are a limitation of the 
study. We decided not to perform statistical data manipu-
lation using multiple imputation to fill in missing values. 
This has been supported by comprehensive simulation 
study that suggests available statistical techniques for data 
manipulation are naive and do not take into account the 
complexity of missing data mechanism.36 As a result, per 
protocol analyses have been presented.
There was a difference between phases 1 and 2 in the 
characteristics of the day of surgery and surgical category. 
These two variables are correlated in that surgical specialty 
teams are scheduled to operate on certain days of the 
week. This was an unfortunate but not highly significant 
confounder in the analysis. To examine the potential for 
various patient, surgery and admission characteristics to 
confound the comparison of adverse events rates, logistic 
regression was conducted and the ORs adjusted for signif-
icant confounders.
This was a quasi-experimental study which had the 
natural limitation of all before–after studies with no 
parallel control group. There may be factors external 
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to the implementation of the PACT that increased or 
decreased surgical risk over the duration of the study. 
Determining the impact of sensitisation of the nursing 
staff to the PACT tool would require a full-scale cluster 
randomised controlled trial (RCT). Similar study designs 
are common in this area,8 32 37 38 as running a cluster RCT 
is not always a pragmatic option. Sensitisation is highly 
correlated with improvement in the early intervention 
implementation period and as time passes its effect will 
be diluted.
conclusions
Using a structured observation, response and discharge 
chart in PACU enhanced nurses’ recognition and 
response to patients who experienced clinical deteriora-
tion. Furthermore, it resulted in reduced length of stay 
for patients who experienced an adverse event in PACU 
and was cost-effective. This study provides evidence of 
a relatively high overall risk to patient safety following 
surgery, with one in four elective surgical patients experi-
encing an adverse event. If a patient had an adverse event 
in PACU, this triggered greater response by nurses in the 
post-implementation phase, through the use of the PACT. 
There was a consequent decrease in the rates of clinical 
deterioration and cardiac events following discharge 
from PACU. These findings highlight the importance of 
close patient monitoring in the immediate postoperative 
period, in PACU and continuing on the ward.
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